BadreNicolas Profile Banner
Nicolas Badre Profile
Nicolas Badre

@BadreNicolas

Followers
3K
Following
12K
Media
397
Statuses
3K

Psychiatrist: Forensic, Clinical, Psychotherapy Co-Author: Essential Psychopathology & Its Treatment, 5th Ed Teacher: Psychiatry, MFT, Law School

Joined January 2022
Don't wanna be here? Send us removal request.
@BadreNicolas
Nicolas Badre
7 days
New Article - Antidepressant Use and Withdrawal "Antidepressant withdrawal reactions may be less rare and more complex, severe, and long-lasting in some patients than previously appreciated." Clinical care points • Avoid reflexively diagnosing relapse; consider withdrawal as
9
45
164
@BadreNicolas
Nicolas Badre
21 hours
One of my fears with universal mental health screening is that simply educating about disorders like ADHD has significant consequences for on self-perception. In this study, a seemingly innocuous ADHD awareness workshop doubled self-perception of ADHD in healthy young adults
22
39
147
@BadreNicolas
Nicolas Badre
1 day
The sad road to polypharmacy often starts with polydiagnosing. Mental illness exists and can be tragic; let’s not turn it into a cacophony of juxtaposed labels. Good care often involves “de-diagnosing.” https://t.co/iDHf0gJOOx
@Dividend__Doc
Dr. Divs
2 days
@AllenFrancesMD I review dozens of cases daily for a major payer. every case has 4-5 diagnoses. MDD, PTSD, GAD, and, of course, schizoaffective disorder! And maybe OCD too! Nearly all inpatients now have hallucinations - even standard admits for SI. The field is in a very sorry state.
3
11
46
@BadreNicolas
Nicolas Badre
7 days
More clinical care points prior to prescribing antidepressants • Consider non-pharmacological treatments as a first-line option for depression. • Discuss all reasonable alternatives with the patient before prescribing antidepressants. • If prescribing antidepressants, use the
1
1
21
@BadreNicolas
Nicolas Badre
7 days
More clinical care points for tapering • Stay up-to-date on emerging evidence regarding safe deprescribing. • Minimize multiple medication changes at once; avoid switching medications while tapering. • Exercise increased caution in certain patients (e.g., pregnancy, suicidal
2
0
19
@BadreNicolas
Nicolas Badre
8 days
The 2023 Medicare & Medicaid spending on psychiatric drugs in America equals the 2023 GDP of Iceland: $31B. Based on summing up publicly available CMS gross data. Note that some of this cost is spread among states, fed, enrollees, and may not include certain rebates.
0
0
2
@JCPjournal
Journal of Clinical Psychopharmacology
8 days
In a new JCP article and podcast episode, Drs. @BadreNicolas and Eric Geier present a practical #anticholinergic equivalence table to help clinicians assess and minimize psychotropic anticholinergic burden. 🎧 Podcast: https://t.co/2yItZ0MEQm 📰 Article: https://t.co/J6JW6wvI0Q
0
1
1
@BadreNicolas
Nicolas Badre
9 days
Patients often come in wanting to be told what to do or asking for the “coping skill” that will make their problems go away. I often answer something like, “A better therapy would give you the strength and confidence to find and trust your own answers rather than seeking mine.”
3
2
32
@BadreNicolas
Nicolas Badre
15 days
Podcast link -
0
0
4
@BadreNicolas
Nicolas Badre
15 days
New Podcast: Anticholinergic Side Effects in Psych Meds @JCPjournal Come learn: 1. Why anticholinergic burden matters 2. Our equivalency scale vs. others 3. Sedation ≠ anticholinergic 4. Antihistamine ≠ anticholinergic 5. Surprising findings + practical tips Thank you JCP for
@BadreNicolas
Nicolas Badre
3 months
Don’t forget anticholinergics side effects! Unlike opioids or benzodiazepines, anticholinergics side effects—confusion, sedation, even possible dementia risk—often fly under the radar. There had already been attempts at making anticholinergic risk tables; our new paper improves
2
18
82
@BadreNicolas
Nicolas Badre
17 days
REFS: • An article from Psych News - https://t.co/ORl41tmRpF • A copy of the DEA letter - https://t.co/W8Qxrz9muk • ADHD data: https://t.co/nDAveq1qLr https://t.co/bcQE78gSTE Other Metadate CD adverising
0
1
2
@BadreNicolas
Nicolas Badre
17 days
"Not Doing Anything Wrong" In 2001, the DEA sent a cease-and-desist letter to the maker of ADHD drug Metadate CD for advertising featuring a superhero saying, “Kids, I’ll be there when you need me!” They responded, "not doing anything wrong," to what was called “the biggest and
8
8
27
@BadreNicolas
Nicolas Badre
17 days
Misogynistic ones
1
1
10
@BadreNicolas
Nicolas Badre
17 days
More stimulants
1
1
7
@BadreNicolas
Nicolas Badre
17 days
More sedatives Butiserpine (sedative + antipsychotic c~1955)
1
0
7
@BadreNicolas
Nicolas Badre
17 days
Old psychotropic medication commercials. Stimulants "Suddenly... life was worth living" "If the individual is depressed" "Stay fit and slim" "When the aged patient is depressed" Sedatives "You prescribe sleep" "Relief comes fast and comfortably" "Life without frenzy" "She
9
11
50
@BadreNicolas
Nicolas Badre
19 days
A few things that increase your odds of being on psych meds more than a PhD Demographics • Age • Womanhood • Living in America Events • Death of a loved one • Trauma • Unemployment
@LinkofSunshine
Basil🧡
20 days
There is almost no other cause we've ever found that increases your odds of needing psychiatric medication more than being 5 years into your PhD
7
5
34
@BadreNicolas
Nicolas Badre
22 days
Childhood Stimulant Use and Future Drug Use In the 1990s, Lambert and Hartsough published a longitudinal study of 492 children over 20 years. They compared ADHD with and without stimulants to controls and examined outcomes in terms of drug dependence in adulthood. The findings
@DrMcFillin
Dr. Roger McFillin
28 days
What happens when you ask a Columbia University Psychiatrist to prove ADHD is real? 2 hours of admissions that undermine his entire profession, followed by a frantic email from his research assistant demanding "factual corrections." This is my response on Substack. link in
2
1
4
@MarkLRuffalo
Mark L. Ruffalo
22 days
@RecoveryDoctor For those who know anything about the history of psychiatry, skepticism is the only rational approach to novel treatments.
2
2
33